Sanofi
Sanofi and Regeneron’s Praluent approved in Europe to reduce CV risk
March 18, 2019Research and Development, Sales and Marketing Regeneron, Sanofi, cardiovascular, heart, praluent
Sanofi and Regeneron’s Praluent (alirocumab) has been awarded approval by the European Commission, it has emerged, as a therapy to …
FDA expands Dupixent indication to include moderate-to-severe atopic dermatitis in adolescent patients
March 12, 2019Manufacturing and Production, Sales and Marketing Dupixent, Regeneron, Sanofi, pharma
Partners Sanofi and Regeneron have both revealed that their jointly developed drug Dupixent (dupilumab) has been authorised by the FDA …
FDA advisory panel recommends Sanofi’s dengue vaccine in children, but rejects its use in adults
March 11, 2019Sales and Marketing FDA, Sanofi, US, Vaccine, dengue, dengvaxia, pharma
Dengvaxia, Sanofi’s vaccine for dengue fever, has been burdened with further negative scrutiny after the FDA’s vaccine advisory panel passed …
Top Ten most popular articles on Pharmafile.com this week!
March 1, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GP, Michael Cohen, Novartis, Roche, Sanofi, Senate, UK, crispr, top 10
As the CRISPR twins’ story unfolds, scientists revealed that the Chinese babies were likely altered in a way that improves …
Philippines Department of Justice recommends charges against six Sanofi officials
March 1, 2019Medical Communications Philippines, Sanofi, dengue, dengvaxia, vaccines
The Philippine Justice Ministry has said it has found probably cause to charge officials working for French drugmaker Sanofi over …
Sanofi’s Dupixent improves symptoms in rhinosinusitis with nasal polyps at Phase 3
February 27, 2019Research and Development Dupixent, Sanofi, pharma, rhinosinusitis
New data has been released on Sanofi’s Dupixent (dupilumab), derived from two Phase 3 trials, illustrating the drug’s efficacy In …
Jury upholds Amgen’s patent validity for Repatha, deflecting challenge from Sanofi and Regeneron
February 26, 2019Manufacturing and Production, Sales and Marketing Amgen, Regeneron, Repatha, Sanofi, patent, pharma
Amgen is celebrating after a Delaware jury backed the validity of two of its patents against challenges from Regeneron and …
Philippines’ FDA halts sales of Sanofi’s dengue vaccine
February 19, 2019Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
The marketing authorisation for Sanofi’s dengue vaccine Dengvaxia has been revoked in the Philippines after the country’s Food and Drug …
Pharma chiefs will testify at Senate hearing on rising drug prices
February 7, 2019Sales and Marketing CEO, J&J, JJ, Pfizer, Sanofi, Senate, pharma, pricing
The Chief Executives of Pfizer, Sanofi and Bristol-Myers Squibb have said that they will join four other pharma execs in …
FDA approves first therapy for acquired thrombotic thrombocytopenic purpura: Sanofi’s Cablivi
February 7, 2019Sales and Marketing Calblivi, FDA, Sanofi, acquired thrombotic thrombocytopenic purpura, pharma
Following swiftly on the heels of the previous success with the announcement of positive Phase 3 data for Icaria in …
Sanofi’s Icaria combo extends progression-free survival in multiple myeloma at Phase 3
February 6, 2019Research and Development Icaria, Sanofi, multiple myeloma, pharma
Sanofi has continued to make progress in the development of Icaria (isatuximab), with the company announcing that the therapy met …
Sanofi will pay Regeneron $582m in deal restructuring
January 7, 2019Sales and Marketing Deals, Regeneron, Sanofi, biotech, pharma
French pharmaceutical giant Sanofi will pay US biotech Regeneron $582 million, as part of a restructuring of an earlier deal …
Boehringer’s France restructure will cull over 300 jobs
December 11, 2018Manufacturing and Production Boehringer, Sanofi, job cuts, pharma
Boehringer Ingelheim is set to follow in the recent steps of Sanofi with the announcement of a cull of over …
Top Ten most popular articles on Pharmafile.com this week!
December 7, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cancer, Diagnostics, Sanofi, Takeda, brexit
Takeda’s acquisition of Shire finally got the go-ahead this week as 88% of shareholders voted in favour of French CEO …
Sanofi announce cull of 670 French jobs
December 6, 2018Business Services, Manufacturing and Production CGT, France, Jobs, Macron, Sanofi, gilet jaunes, yellow jackets
French pharma giant Sanofi has said that it will cut 670 jobs in France over the next two years. The …
